New study aims to stop mild brain injury symptoms from lingering

NCT ID NCT07341074

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether early, symptom-guided therapy can prevent long-term complaints after mild traumatic brain injury. About 655 adults aged 18-70 will receive either physical/occupational therapy, psychoeducation by phone, or usual care. The goal is to reduce post-concussion symptoms and improve quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

physical therapy, occupational therapy, and psychoeducation via telephone counselling

What this could lead to

If it works, this could provide an effective early treatment to reduce persistent symptoms after mild brain injury and help people return to daily life sooner.

What could go wrong

This is a relatively early-stage trial with no prior evidence for these specific interventions, and the effect may be small or not better than usual care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MILD TRAUMATIC BRAIN INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Concussion traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Medical Center Groningen

    RECRUITING

    Groningen, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••